| Line Item | 2023-12-30 | Y/Y |
|---|---|---|
| Revenue | $1.48B | -0.7% |
| R&D Expense | $2.6M | +9.1% |
| SG&A Expense | $452.1M | -6.0% |
| Operating Income | $60.9M | +52.7% |
| Pre-tax Income | -$7.4M | +49.7% |
| Income Tax | $2.2M | +24.8% |
| Net Income | -$9.6M | +41.7% |
| EPS (Basic) | -$0.05 | +37.5% |
| EPS (Diluted) | -$0.05 |
| Line Item | 2023-12-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $38.6M | +24.0% |
| Accounts Receivable | $103.5M | +19.0% |
| Inventory | $382.7M | -21.8% |
| Current Assets | $548.0M | -13.2% |
| Total Assets | $2.33B | -5.6% |
| Current Liabilities | $223.1M | +3.6% |
| Long-term Debt | $753.6M | -17.6% |
| Line Item | 2023-12-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $238.0M | +100.0% |
| Investing Cash Flow | -$67.9M | +6.8% |
| Financing Cash Flow | -$162.0M | -463.9% |
| +37.5% |
| Total Liabilities |
| $1.18B |
| -10.5% |
| Stockholders' Equity | $1.15B | -0.2% |